These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32990838)

  • 1. Therapy of traditional Chinese medicine in Candida spp. and Candida associated infections: A comprehensive review.
    Liu C; Shao J
    Fitoterapia; 2024 Jul; 177():106139. PubMed ID: 39047847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the application of nanoparticles for the treatment of fungal infections: A review.
    Zhu X; Chen Y; Yu D; Fang W; Liao W; Pan W
    Mycology; 2024; 15(1):1-16. PubMed ID: 38558835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antifungal effect of plant extracts on oral
    Maziere M; Andrade JC; Rompante P; Rodrigues CF
    Crit Rev Microbiol; 2024 Mar; ():1-11. PubMed ID: 38497208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green synthesis of silver nanoparticles derived from lemon and pomegranate peel extracts to combat multidrug-resistant bacterial isolates.
    Abdelrazik M; Elkotaby HH; Yousef A; El-Sayed AF; Khedr M
    J Genet Eng Biotechnol; 2023 Oct; 21(1):97. PubMed ID: 37815647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-Based Strategies to Combat Multidrug-Resistant
    Hetta HF; Ramadan YN; Al-Kadmy IMS; Ellah NHA; Shbibe L; Battah B
    Pathogens; 2023 Aug; 12(8):. PubMed ID: 37623993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal Properties of Biogenic Selenium Nanoparticles Functionalized with Nystatin for the Inhibition of
    Nile SH; Thombre D; Shelar A; Gosavi K; Sangshetti J; Zhang W; Sieniawska E; Patil R; Kai G
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallic Nanosystems in the Development of Antimicrobial Strategies with High Antimicrobial Activity and High Biocompatibility.
    Skłodowski K; Chmielewska-Deptuła SJ; Piktel E; Wolak P; Wollny T; Bucki R
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal Nanoparticles to Combat
    Carmo PHFD; Garcia MT; Figueiredo-Godoi LMA; Lage ACP; Silva NSD; Junqueira JC
    Microorganisms; 2023 Jan; 11(1):. PubMed ID: 36677430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrospun Polyacrylonitrile Silver(I,III) Oxide Nanoparticle Nanocomposites as Alternative Antimicrobial Materials.
    Wang WB; Pan CY; Huang EY; Peng BJ; Hsu J; Clapper JC
    ACS Omega; 2022 Dec; 7(51):48173-48183. PubMed ID: 36591150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterylglucosides in Fungi.
    Pereira de Sa N; Del Poeta M
    J Fungi (Basel); 2022 Oct; 8(11):. PubMed ID: 36354897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis.
    León-Buitimea A; Garza-Cervantes JA; Gallegos-Alvarado DY; Osorio-Concepción M; Morones-Ramírez JR
    Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities for Nanomedicine in
    Wang PW; Lee WT; Wu YN; Shieh DB
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438998
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update.
    Mba IE; Sharndama HC; Osondu-Chuka GO; Okeke OP
    Infect Dis (Lond); 2021 Aug; 53(8):559-580. PubMed ID: 33905282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bursting the Virulence Traits of MDR Strain of
    Abid S; Uzair B; Niazi MBK; Fasim F; Bano SA; Jamil N; Batool R; Sajjad S
    Int J Nanomedicine; 2021; 16():1157-1174. PubMed ID: 33623380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of nanoparticles as alternative therapeutic agents against Candida infections: an up-to-date overview and future perspectives.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2020 Sep; 36(11):163. PubMed ID: 32990838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal resistance in pathogenic fungi.
    Perea S; Patterson TF
    Clin Infect Dis; 2002 Nov; 35(9):1073-80. PubMed ID: 12384841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapy.
    Gozalbo D; Roig P; Villamón E; Gil ML
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):117-35. PubMed ID: 15180460
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.